Chemtura (CHMT) Misses Q4 EPS by 7c

Chemtura (NYSE: CHMT) reported Q4 EPS of $0.34, $0.07 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $385 million versus the consensus estimate of $386.47 million.

For earnings history and earnings-related data on Chemtura (CHMT) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform
• Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight